The global intraocular lens market growth forecasted to transform from USD 4.2 billion in 2023 to USD 6.0 billion by 2029, driven by a CAGR of 6.3%. Increasing in the number of cataract surgeries, growing awareness of minimally invasive surgeries, growing number of old age population, and rise in the technological advancement in IOLs are the major factor driving the growth of this market. Manufacturers of intraocular lenses continuously develop cutting-edge, new technology that is safer, more efficient, and more effective than existing lenses. Additionally, they are creating new technology that will enable surgeons to more precisely and successfully identify and treat cataract surgeries with intraocular lenses. Manufacturers of intraocular lens are connecting with a broader international market and supplying globally with their products. This is contributing to the expansion of the global intraocular lens market.

Download an Illustrative overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263730551

Browse in-depth TOC on "Intraocular Lens Market"

150 - Tables

120 - Figures

300 – Pages

Premium IOLs is accounted for the fastest growing segment of the global intraocular lens market

Types of Intraocular lens market further segmented into Monofocal IOLs, Premium IOLs, Phakic IOLs, and others. Premium IOLs accounted for the fastest growing segment in the Intraocular lens market. IOLs with functionalities beyond simple vision correction are becoming increasingly popular among patients. They are looking for lenses that can improve near and intermediate vision, treat astigmatism, and manage presbyopia. Exquisite IOLs that meet these requirements and produce better visual results include multifocal, toric, and extended depth of focus (EDOF) lenses. Premium IOLs contribute to this by offering faster visual recovery, better vision quality, and improved quality of life. This emphasis on patient satisfaction further strengthens the demand for premium IOLs.\

Aspheric Monofocal IOLs segment is accounted for the highest share of the mono-focal intraocular lens market

IOLs come in several types and aspheric monofocal IOLs holds a significant share in the intraocular lens market. Because of their non-spherical design, aspheric IOLs decrease the effect of spherical aberration, a common optical flaw that can result in haze and blurred vision. When compared to conventional spherical lenses, certain aspheric mono focal IOLs provide a greater depth of focus. Patients may benefit from improved eyesight at intermediate distances, which will improve their capacity to conduct everyday tasks.

Hospitals accounted for highest share in the end user segment of the intraocular lens market

In End user segment, intraocular lens market is segmented into Hospitals, Ophthalmology Clinics, Eye Research Institutes, and Others. Hospital segments hold the highest market share in intraocular lens market. Factors such as large number of cataract surgeries performed, high adoption of novel technology in eye surgeries related to intraocular lenses, and comprehensive patient care, including pre-operative consultations, surgery, and post-operative follow-up helps the highest market share of the segment.

Asia Pacific is expected to grow at a significant CAGR during the forecast period

The population of Asia Pacific is the largest in the world, and a considerable proportion of that population is in the age range where cataracts are most likely to occur. There is a significant patient population for cataract surgery and IOL implantation due to the high frequency of cataracts. Families and individuals now have more discretionary income thanks to the Asia-Pacific area. Because of their increased purchasing power, more people are now able to purchase high-quality IOL alternatives and cataract surgery.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=263730551

Key Market Players of Intraocular Lens Industry:

The prominent players in the intraocular lens market are Alcon Inc. (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Bausch & Lomb (US), STAAR Surgical (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK Co., Ltd. (Japan), LENSTEC, Inc. (US), Rayner Group (England), Beaver-Visitec International (US).

Following is a list of the major players (supply-side) in the intraocular lens market that this study refers to:

• By Company Type: Tier 1- 60%, Tier 2- 30%, and Tier 3- 10%
• By Designation: Director Level—30%, C-level- 50%, and Others- 20%
• By Region: North America-35%, Europe-20%, Asia Pacific-25%, Latin America- 15%, and Middle East and Africa-5%

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=263730551

Intraocular Lens Market Recent Developments:

• In September 2023 Carl Zeiss Meditec AG launched AT ELANA 841P IOL, a single-piece hydrophobic acrylic implant which is based on the optical design of the single-piece, four point-haptic AT LISA tri 839MP.
• In January 2023, Bausch & Lomb (US) acquired AcuFocus (US) which is an ophthalmic medical device company that has delivered breakthrough small aperture intraocular technology to address diverse unmet needs in eye care.
• In March 2022, Alcon Inc. launched of Clareon Portfolio in the U.S. to strengthen leadership in IOL innovation. Clareon offers sharp vision, and it is designed to help reduce glare and posterior capsular opacification. The lens' proven STABLEFORCE Haptics provide superior axial and rotational stability.
• In March 2022, STAAR surgical received product approval from USFDA for EVO+ Visian Implantable Collamer Lens for the correction of myopia and myopia with astigmatism.

Intraocular Lens Market - Key Benefits of Buying the Report:

Analysis of key drivers (Growing number of old age population, increasing in the number of cataract surgeries, and Rise in the technological advancement in IOLs), restraints (rising the cost of intraocular lenses) opportunities (Potential growth opportunities in emerging countries), and challenges (shrinking in the workforce and skilled surgeons in intraocular lens industry) influencing the growth of the intraocular lens market.

• Product Development/innovation: Comprehensive details on new technologies, R&D initiatives, and product and service launches for intraocular lens market.
• Market Development: Comprehensive data on attractive markets, and the research analyzes the global intraocular lens market.
• Market Diversification: Detailed information on emerging products and services, unexplored regions, current trends, and investments in the intraocular lens market.
• Competitive Assessment: Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the intraocular lens market like Alcon Inc. (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Bausch & Lomb (US), STAAR Surgical (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK Co., Ltd. (Japan), LENSTEC, Inc. (US), Rayner Group (England), Beaver-Visitec International (US), Ophtec B.V. (Netherlands), SAV-IOL SA (Switzerland), Appasamy Associates Private Limited (India), Atia Vision, Inc. (US), Biotech vision care (Switzerland), Teleon Surgical BV (Netherlands), OMNI Lens Pvt. Ltd. (India), EyeKon Medical, Inc. (US), Humanoptics Holding AG (Germany), Care Group (India), SIFI S.p.A. (Italy), Hanita Lenses Ltd (Israel), Excellent Hi-Care Pvt Ltd. (India), and Advin Health Care (India)

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/